CAPLIPOINT vs LUPIN: Stock Comparison

Caplin Point Laboratories Limited vs Lupin Limited

Live data: 22 July 2026, 3:02 PM IST • Source: NSE and company filings

Lupin Limited is the larger company by market capitalisation. Caplin Point Laboratories Limited shows lower leverage and a higher net margin, while Lupin Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Caplin Point Laboratories Limited and Lupin Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, CAPLIPOINT is more favourable on 3 of 13 scored metrics and LUPIN on 10These counts are context-free and are not an overall rating.

Caplin Point Laboratories Limited

Key Differences

Market Cap

LUPIN is the larger company

₹1.1 L Cr vs ₹18,839 Cr

P/E Ratio

LUPIN has a lower P/E

21.56x vs 31.01x

P/B Ratio

LUPIN has a lower P/B

5.12x vs 5.54x

EPS

LUPIN has higher earnings per share

₹116.56 vs ₹83.98

Dividend Yield

LUPIN has a higher dividend yield

0.48% vs 0.3%

Revenue Growth (TTM YoY)

LUPIN has faster revenue growth

31.9% vs 19%

EPS Growth (TTM YoY)

LUPIN has faster EPS growth

89% vs 19.4%

Qtr Sales Growth

LUPIN has stronger quarterly sales growth

31.9% vs 19.4%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

Metric	CAPLIPOINT	LUPIN
Sector	Healthcare	Healthcare
Industry	Pharmaceuticals	Pharmaceuticals

Price

Metric	CAPLIPOINT	LUPIN
Live Price	₹2,480.8	₹2,408.4
Day Change	-4.88%	-4.23%
Volume	1.65 L	10.37 L
52-Week High	₹2,699	₹2,529.5
52-Week Low	₹1,500.3	₹1,836.8
Distance from 52W High	-8.08%	-4.79%

Valuation

Metric	CAPLIPOINT	LUPIN
Market Cap	₹18,839 Cr	₹1.1 L Cr
P/E Ratio	31.01x	21.56x
P/B Ratio	5.54x	5.12x
EPS	₹83.98	₹116.56
Book Value	₹462.02	₹491.29
Dividend Yield	0.3%	0.48%

Growth

Metric	CAPLIPOINT	LUPIN
Revenue Growth (TTM YoY)	19%	31.9%
EPS Growth (TTM YoY)	19.4%	89%
Qtr Sales Growth	19.4%	31.9%
Qtr Profit Growth	19.3%	101%

Profitability & Leverage

Metric	CAPLIPOINT	LUPIN
ROE	20.6%	29.1%
ROCE	24.6%	30.3%
Net Margin	29.2%	17.65%
Operating Margin	34.8%	31.5%
Debt to Equity	0x	0.29x

Shareholding

As of Mar 2026 • change vs previous quarter

Metric	CAPLIPOINT	LUPIN
Promoter Holding	70.57%	46.57%▼ 0.04 pp
FII Holding	6.15%▼ 0.44 pp	21.71%▲ 0.22 pp
DII Holding	2.14%▲ 0.09 pp	25.32%▼ 0.26 pp
Public Holding	21.14%▲ 0.35 pp	6.11%▲ 0.08 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Caplin Point Laboratories Limited and Lupin Limited.

Related Comparisons

Infosys vs TCS HDFC Bank vs ICICI Bank Axis Bank vs Kotak Mahindra Bank HCL Technologies vs Wipro Hindustan Unilever vs ITC Maruti Suzuki vs Tata Motors

Browse all stock comparisons →

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.